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Abstract
Background: Although a sizeable budget is available for HIV/AIDS control in Thailand, there will never be enough 
resources to implement every programme for all target groups at full scale. As such, there is a need to prioritize HIV/ 
AIDS programmes. However, as of yet, there is no evidence on the criteria that should guide the priority setting of HIV/ 
AIDS programmes in Thailand, including their relative importance. Also, it is not clear whether different stakeholders 
share similar preferences.
Methods: Criteria for priority setting of HIV/AIDS interventions in Thailand were identified in group discussions with 
policy makers, people living with HIV/AIDS (PLWHA), and community members (i.e. village health volunteers (VHVs)). 
On the basis of these, discrete choice experiments were designed and administered among 28 policy makers, 74 
PLWHA, and 50 VHVs.
Results: In order of importance, policy makers expressed a preference for interventions that are highly effective, that 
are preventive of nature (as compared to care and treatment), that are based on strong scientific evidence, that target 
high risk groups (as compared to teenagers, adults, or children), and that target both genders (rather than only men or 
women). PLWHA and VHVs had similar preferences but the former group expressed a strong preference for care and 
treatment for AIDS patients.
Conclusions: The study has identified criteria for priority setting of HIV/AIDS interventions in Thailand, and revealed 
that different stakeholders have different preferences vis-à-vis these criteria. This could be used for a broad ranking of 
interventions, and as such as a basis for more detailed priority setting, taking into account also qualitative criteria.
Background
While the number of new HIV positive cases in Thailand 
decreases [1-3], HIV/AIDS continues to take a large toll 
in the country with 610,000 prevalent cases and approxi­
mately 30,000 deaths in 2007 [2]. A wide array of HIV/ 
AIDS control programmes has been implemented to con­
front the epidemic since the first wave of infections in the 
mid-1980s [1,4]. Thailand's current national plan for 
HIV/AIDS prevention and alleviation, 2007-2011 [3] 
aims to: (i) integrate AIDS prevention, care, treatment, 
and impact reduction implementation into service provi­
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F u ll lis t  o f  a u th o r  in fo rm a t io n  is a v a ila b le  a t  th e  e n d  o f  th e  a r t ic le
sion at all levels; (ii) strengthen community's education 
about AIDS; (iii) enhance capacity of local administration 
in taking responsibility on local HIV/AIDS interventions; 
and (iv) prevent HIV transmission among children in 
schools and high-risk population groups. To date, the 
Thai government provides universal coverage for antiret­
roviral medication to all eligible people living with HIV/ 
AIDS (PLWHA) [5]. However, HIV-related absenteeism 
and the need of informal care (e.g. care givers) have nota­
ble effects on individual PLWHA's economic burden [6].
Although a sizeable budget for implementation of this 
plan is available - approximately US$193 million in 2008 
derived from both the Thai government and the Interna­
tional Monetary Fund [3] - there will never be enough 
resources to implement every programme for all target 
groups at full scale. As such, there is a need to prioritize
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HIV/AIDS programmes within the available budget, and 
to decide on which programmes will receive funding and 
which programmes will not.
A number of criteria can guide this priority setting pro­
cess [7]. First, cost-effectiveness, or efficiency, aims to 
maximize population health given a certain budget. A 
limited number of cost-effectiveness analyses have been 
performed in Thailand [8], including (i) routine offer of 
HIV counseling and testing [9]; (ii) donated blood screen­
ing by nucleic acid testing [10]; (iii) HIV vaccination [11], 
and (iv) the prevention programme of mother-to-child 
transmission of HIV [12]. Secondly, equity or fairness, 
aims to minimize differences in health among population 
groups, with special reference to the severely ill, disad­
vantaged, or vulnerable populations [13]. Thirdly, the 
Thai government may hold preferences to target specific 
population groups, because they are more deserving of 
health care than others. The HIV/AIDS epidemics in 
Thailand concerns various population groups, including 
high-risk groups such as male homosexuals, intravenous 
drug users, and low-risk groups as the general population 
including teenagers, adults, and elderly [4,14]. In addi­
tion, a wide range of other medical (e.g. preference for 
acute care in life threatening situation) and non-medical 
criteria (e.g. preferences for programmes with desirable 
social consequences) may play a role in priority setting 
process [7,14-17].
It is clear that relying on a single criterion, e.g. effi­
ciency, falls short to capture the important moral and 
ethical notions, and is unlikely to be acceptable for most 
policy makers [18-21] including those in Thailand [22]. 
The challenge for policy makers in Thailand is then to 
find the right balance between the various criteria. The 
trade-off a country like Thailand makes between e.g. effi­
ciency and equity criteria can have important implica­
tions, e.g. adopting severity of disease rather than cost- 
effectiveness as guiding principle in the selection of HIV/ 
AIDS interventions - and thus choosing treatment rather 
than prevention-centered strategies - could lead to a large 
number of extra infections in Thailand [14].
However, as of yet, there is no evidence on the criteria 
that should guide the priority setting of HIV/AIDS pro­
grammes in Thailand, including their relative impor­
tance. Also, it is not clear whether different stakeholders 
share similar preferences. It is against this background 
that this paper elicits preferences on the relative impor­
tance of criteria for priority setting of HIV/AIDS pro­
grammes in Thailand from policy makers, PLWHA and 
community members. The study uses discrete choice 
experiments (DCE) to elicit explicit preferences in HIV/ 
AIDS area, and is the first study to do so in this area. The 
technique allows the assessment of the relative impor­
tance of different criteria that influence choice, in this 
case the priority setting of health interventions in HIV/
AIDS control. The technique has shown promising 
results in a number of other disease areas in low-income 
settings [23-25]. The present study can hence be inter­
preted as exploratory, to test the feasibility of the 
approach, and have a first impression of its findings.
Methods
Discrete choice experiments
Discrete choice experiments are a quantitative methodol­
ogy for evaluating the relative importance of the different 
product attributes that influence consumer choice behav­
ior [26]. In such experiments, respondents are asked to 
make choices between hypothetical alternative goods or 
services.
We employed DCE to determine the relative impor­
tance of criteria for priority setting, according to various 
stakeholders. In a DCE, respondents choose their pre­
ferred option from sets of hypothetical scenarios, each 
consisting of a bundle of criteria that describe the sce­
nario in question. The criteria are constant in each sce­
nario, but the levels that describe each criterion may vary 
across scenarios. Analysis of the options chosen by 
respondents in each scenario reveals the extent to which 
each criterion is important to the decision at hand 
[27,28]. Running a DCE involves selection of participants, 
identification of criteria through group discussion, DCE 
design and administration of the DCE survey. These are 
discussed in turn.
Participants
In this study, we chose to explore the views of policy mak­
ers in comparison with two other groups of stakeholders, 
i.e. PLWHA, and community members represented by 
village health volunteers (VHVs).
The policy makers were represented by 28 national - 
and province level decision makers strongly involved in 
health resource allocation decisions in Thailand specifi­
cally on HIV/AIDS. As a first step in the selection pro­
cess, members of the National AIDS Committee were 
asked to participate. As a second step, they were asked to 
nominate other decision-makers meeting the above crite­
rion. A total of 30 decision makers were invited, and 28 
agreed to participate in the study. They were predomi­
nantly male (71.4%), and all being higher educated (bach­
elor degree or more) (Table 1).
The PLWHA were all members of the Thai network for 
people living with HIV/AIDS, representing PLWHA 
groups at the province and regional level in Thailand. In a 
regular network-meeting, we invited the members to par­
ticipate in the present study. In total, 74 out of 85 invited 
PLWHA agreed to participate. They were predominantly 
female (61.1%) with a minority being higher educated.
The community members were represented by VHVs - 
these are community members who have been trained by
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Table 1: General characteristic of respondents
Perspective
Policy makers 
(n = 28)
People living with HIV/AIDS 
(n = 74)
Village Health Volunteers 
(n = 50)
Age (years)
mean (SD) 47.4 (6.9) 33.1 (5.5) 47.6 (9.0)
Gender
male 20 (71.4%) 28 (38.9%) 6 (12.0%)
female 8 (28.6%) 44 (61.1%) 44 (88.0%)
missing - 2 -
Education
lower than bachelor - 44 (61.1%) 40 (80.0%)
bachelor degree 4 (14.8%) 27 (37.5%) 10 (20.0%)
master degree 16 (59.3%) 1 (1.4%) -
doctoral degree 7 (25.9%) - -
missing 1 2 -
Occupation
government officer 27 (100.0%) 1 (1.4%) 4 (8.0%)
private company employee - 4 (5.6%) 3 (6.0%)
agriculturists - 5 (7.0%) 2 (4.0%)
housewives - - 30 (60.0%)
freelancers/self-employee - 54 (76%) 3 (6.0%)
others - 7 (9.8%) 8 (16.0%)
missing 1 3 -
public health providers in order to provide basic health 
care delivery including first aid and necessary health 
information to members of the village they reside in. In 
the selection process, we invited 100 VHVs in a semi­
urban district of Samutprakan province, and out of these, 
50 agreed to participate. They were predominantly 
female (88%), with a minority being higher educated.
Identification of criteria and criteria levels
To define the criteria in DCE, group discussions were 
organized with each group of stakeholders including six 
representatives of that group. As an initial step, two HIV/ 
AIDS interventions were presented. Then participants 
were asked to decide which intervention should be 
funded and reasons for the choices were discussed. The 
discussion was then broadened to discuss general rea­
sons, or criteria, to fund HIV/AIDS interventions, and 
finally agreement was reached on a comprehensive set of 
criteria. Resulting criteria and associated levels from the 
three group discussions were compared. The final selec­
tion of criteria and levels included those that were identi­
fied by two or more discussion groups. This resulted in
identification of one criterion at four levels, two criteria 
at three levels, and two criteria at two levels (Table 2).
DCE design
The DCE was designed on the following principles. To 
avoid information overload from a full factorial of 144 
possible scenarios based on identified criteria and levels 
(41 x 32 x 22), a limited number is chosen on the basis of a 
fractional experimental designs catalogue produced by 
Hahn and Shapiro [29]. The catalogue includes a number 
of orthogonal designs, both full factorial and fractional 
factorial ones, with differing numbers of attributes at dif­
fering numbers of levels. The fractional factorial design - 
fitting the number of identified criteria and levels - 
included a subset of 16 scenarios (representing an 
orthogonal array and minimizing multicollinearity), to 
allow the estimation of all main effects. Each of these 16 
scenarios was paired by fold-over technique. A two-sce­
nario with non-labeled experimental design was 
employed for each choice set. The plausibility of each sce­
nario was evaluated with experts, policy makers, and in a 
pilot study with VHVs. The DCE questions are presented 
in additional file 1.
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Table 2: Attributes and levels
Attributes Levels Level coding Definition
Target group Children (Child) Child 0 - 12 years old
Teenagers Teen 13 - 20 years old
High risk adults HiRisk > 21 years old with high risk behavior e.g. sex workers, 
men who have sex with men, injected drug users, 
pregnant women, etc.
All adults Adults > 21 years old without any specification
Gender of Male Male aiming to male population
target group Female Female aiming to female population
Both genders BothGen not specify gender of target group
Type of Treatment and care of patients HIV aiming to treat HIV infected people (CD4 > 200) and
intervention with HIV (not AIDS) reduce HIV transmission
Treatment and care of patients 
with AIDS
AIDS aiming to treat AIDS patients (CD4 < 200)
Preventing HIV Prevent aiming to prevent general publics from HIV infection
Effectiveness Low effective LoEff less than 50% of participants benefit
High effective HiEff more than 50% of participants benefit
Quality of evidence Weak evidence Weak no evidence but observation and/or expert opinions
on effectiveness Strong evidence Strong evidence from domestic and/or international literatures
DCE survey
The DCE survey was adm inistrated to policy makers 
through face-to-face interview and to the other 
groups by self-administered questionnaires. For the 
latter groups, group meetings were organized to clar­
ify the aims of the DCE survey and the questionnaire. 
At completion of the questionnaire, participants were 
asked to simply rank order the criteria included in the 
DCE on the basis of their importance in priority set­
ting of HIV/AIDS interventions. To standardize and 
maintain quality of the data collection, the group dis­
cussion and interviews were conducted only by the 
first author.
Data analysis
Regression coefficients, average marginal effects, and 
relative contributions were estimated from the 
response data by the statistical software program 
STATA 10.0. Regression coefficients indicate the sign 
of the effect of a variable on the probability of selec­
tion of an intervention. Since the response data is a 
dichotomous outcome - '1' is coded for being chosen, 
with '0' is coded for not being chosen - and dummy 
coding was used to transform the attribute levels into 
L-1 dummy variables in which each dummy is set 
equal to 1 when the qualitative level is present and set 
equal to 0 if it is not.
Binary logistic regression models were used to analyze 
the data, with the following description,
Logit ( P ) = ^0 + ^1-3 Target group + ^4-5 Gender of target group + b6- 7 Type o f intervention 
+ ^ 8  Effectiveness + b 9 Quality o f evidence on effectiveness + e
( 1)
where P is the probability of an intervention being 
selected by the respondents, p0 is the constant term, pi (i = 
1-9) are the coefficients of the model indicating the prob­
ability of selection relative to the reference criterion level, 
and e is the unobservable error term. To control for dif­
ferences in attractiveness of DCE scenarios, dummies 
were added for scenarios to equation (1).
Marginal effects reflect the change in the probability of 
selection of an intervention. These were computed by 
taking the average difference in predicted probability of P 
with and without the variable, while holding the distribu­
tion of the other variables at their sample value, and then 
taking the sample mean of these differences.
The relative contributions were calculated to signify the 
contribution of one criterion to the variation in prefer­
ences explained by the regression model and therefore 
describe the relative importance of the various criteria in 
the choice of interventions. This relative importance 
depends on the variation in the levels that are chosen for 
each of the attributes. Variation explained by the model is 
based on Efron R2[30],
'E fr o n = 1 - X; (y; - p i ) 
Xi (y; -  y )2
( 2 )
A
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where yi indicates the observed choice and m  indicates 
the predicted probability that choice equal to 1. The rela­
tive contributions are calculated by computing Efron's 
R2of the above model minus Efron's R2of the model where 
the criterion is held constant at its sample mean. This 
procedure shows the contribution of criteria irrespective 
of the number of levels they have.
To test whether the decision makings on choice selec­
tions vary between perspectives, the likelihood ratio test 
was analyzed. At the end, as a validity check, the resulting 
rank ordering of attributes derived from DCE exercise 
was compared (presented by the relative contributions) to 
those derived from a simple rank ordering.
Research ethics
This study was approved by Institute for the Develop­
ment of Human Research Protections (IHRP), Ministry of 
Public Health, Thailand. All participants provided their 
written informed consent for the discussion and the 
interview.
Results
Table 3 shows the results of logistic regression analysis 
and marginal effects calculation from the DCE response 
data, for each group of stakeholders. First, policy makers 
expressed a preference for highly effective interventions 
compared to those with low effectiveness, as indicated by 
the marginal effects. These show that the former inter­
ventions have a 38.5% higher probability of being selected 
than the latter. The next important criterion is interven­
tion type, and policy makers expressed a preference for 
preventive interventions, followed by treatment of and 
care for HIV-infected people, and treatment of and care 
for AIDS-patients. The marginal effects show that pre­
ventive interventions have a 33% higher probability to be 
selected than the latter. Next, policy makers expressed a 
preference for interventions with strong evidence on 
intervention effectiveness compared to weak evidence. 
Also, policy makers preferred interventions that target 
high risk groups, followed by teenagers, adults, and chil­
dren. Policy makers revealed a weak preference for gen­
der of target group, with a priority to target both genders, 
followed by males and then females.
Second, PLWHA had similar preferences as policy 
makers with some exceptions. Most notably, PLWHA 
expressed a strong preference for treatment or care for 
AIDS patients, and the probability of selection of these 
interventions is 24.5% higher than treatment and care for 
HIV-infectious people. Moreover, they expressed a strong 
preference for targeting both genders rather than one
gender only. Third, VHVs preferences cohered largely 
with that of policy makers.
The different models for policy makers, PLWHA and 
VHVs demonstrate a good fit as indicated by the pseudo 
R2, and Hosmer-Lemeshow chi-square. The likelihood 
ratio test presents that the preferences on the criteria of 
each group of stakeholders are significantly different.
The contribution R2 indicates the overall importance of 
criteria (Table 4). Policy makers considered intervention 
effectiveness as the most important criterion, followed by 
intervention type, quality of evidence, target group, and 
gender of target group. PLWHA considered gender of 
target group as most important criterion, followed by 
intervention type, intervention effectiveness, quality of 
evidence, and target group. VHVs considered interven­
tion effectiveness as most important, followed by target 
group, gender of target group, type of intervention, and 
quality of evidence. Table 4 also shows the results of the 
simple rank ordering of criteria, and it reveals large over­
laps for the policy makers, but less so for PLWHA and 
VHVs.
Discussion and Conclusions
The study has identified criteria for priority setting of 
HIV/AIDS interventions in Thailand using perspective of 
policy makers, PLWHA, and VHVs, and revealed that dif­
ferent stakeholders have different preferences vis-à-vis 
these criteria. A number of observations can be made.
First, the findings show that policy makers give priority 
to preventing HIV interventions, and targeting high risk 
populations. This is in line with the Thai national policy 
on priority setting of HIV interventions, which focuses 
on prevention among people who may be the most at risk 
of transmitting HIV [3]. Yet, although policy makers may 
put higher priority on HIV prevention programs, it is 
obvious that therapy cannot be neglected [3,14,19]. The 
Thai national HIV/AIDS plan emphasizes integrating 
HIV and AIDS prevention and treatment programs 
[3,31]. The emphasis on intervention effectiveness and 
related quality of evidence confirms the importance that 
is attributed to evidence-based medicine in Thailand [8].
Secondly, the study reveals large similarities in the pref­
erences for criteria for HIV/AIDS interventions between 
policy makers and VHVs. This may indicate that the pref­
erences of community members (based on the sample 
used) are well reflected through decisions made by policy 
makers. This study also highlights the differences in pref­
erences between PLWHA and the other stakeholder 
groups. The preferences of the former for care and treat­
ment may reflect self-interests, whereas the preferences 
of the latter may reflect preferences for the society at 
large.
Thirdly, our findings show overlap between the ranking 
of criteria resulting from DCE and as obtained from sim-
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Table 3: Discrete choice model results and marginal effects by perspective
Perspectives
Policy makers People living with HIV/AIDS Village Health Volunteers
Criteria
Target group
Levels
Child
Coefficient
(95% CI)
(p-value) Marginal effect Coefficient
(95% CI)
(p-value) Marginal effect Coefficient
(95% CI)
(p-value) Marginal effect
Teen 1.049* 
(0.445, 1.654)
(0.001) 0.183 0.135 
(-0.169, 0.440)
(0.385) 0.030 0.830* 
(0.464, 1.196)
(0.000) 0.181
HiRrisk 1.153* 
(0.502, 1.803)
(0.001) 0.199 0.022 
(-0.323, 0.368)
(0.900) 0.005 0.314 
(-0.105, 0.734)
(0.142) 0.069
Gender of target 
group
Adults
Male
0.023 
(-0.470, 0.517)
(0.926) 0.004 -0.279 
(-0.575, 0.017)
(0.065) -0.061 -0.249 
(-0.609, 0.112)
(0.176) -0.054
Female -0.256 
(-0.762, 0.250)
(0.321) -0.043 0.082 
(-0.184, 0.348)
(0.544) 0.018 0.196 
(-0.123, 0.514)
(0.229) 0.043
Type of intervention
BothGen
HIV
0.266 
(-0.131, 0.663)
(0.189) 0.045 1.132* 
(0.911, 1.354)
(0.000) 0.255 0.724* 
(0.458, 0.990)
(0.000) 0.161
AIDS -0.493* 
(-0.904, -0.081)
(0.019) -0.088 1.091* 
(0.869, 1.313)
(0.000) 0.245 -0.476* 
(-0.744, -0.208)
(0.001) -0.105
Effectiveness
Prevent
LoEff
1.967* 
(1.450, 2.485)
(0.000) 0.333 0.212 
(-0.052, 0.476)
(0.116) 0.047 0.246 
(-0.078, 0.569)
(0.137) 0.054
Quality of evidence
HiEff
Weak
1.983* 
(1.643, 2.323)
(0.000) 0.385 0.627* 
(0.454, 0.800)
(0.000) 0.140 1.185* 
(0.973, 1.395)
(0.000) 0.275
on effectiveness Strong
Log likelihood 
Pseudo R2 
Hosmer-Lemeshow chi-square (p- 
value)
1.310* 
(0.976, 1.645)
(0.000)
-424.4532
0.2747
1.36
(0.995)
0.237 0.356* 
(0.183, 0.528)
(0.000)
-1434.3323
0.0992
2.79
(0.947)
0.079 0.349* 
(0.139, 0.560)
(0.001)
-963.3818
0.0984
1.87
(0.985)
0.077
*Significant variables (p < 0.05) 
Likelihood ratio test (p < 0.000)
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Table 4: Rank ordering of criteria in simple ranking and DCE exercise
Perspective
Policy makers People living with HIV/AIDS Village Health Volunteers
Simple
ranking
Rank 1 Effectiveness Target group Target group
Rank 2 Target group Effectiveness Gender of target group
Rank 3 Type of intervention Quality of evidence Type of intervention
Rank 4 Quality of evidence Type of intervention Effectiveness
Rank 5 Gender of target group Gender of target group Quality of evidence
DCE R2 R2 R2
Rank 1 Effectiveness 0.1 
52
Gender of target group 0.058 Effectiveness 0.075
Rank 2 Type of intervention 0.0 
91
Type of intervention 0.042 Target group 0.017
Rank 3 Quality of evidence 0.0 
53
Effectiveness 0.019 Gender of target group 0.016
Rank 4 Target group 0.0 
15
Quality of evidence 0.008 Type of intervention 0.013
Rank 5 Gender of target group 0.0 
14
Target group 0.003 Quality of evidence 0.006
DCE, discrete choice experiments; R2, contribution R2
ple ranking for policy makers, but less so for other stake­
holders. This may indicate validity and hence usefulness 
of DCE for (well-educated) policy makers, but possibly 
less so for other (less-educated) stakeholders.
Recently, a number of empirical priority setting studies 
have included the views of different stakeholders, such as 
patients and community members, besides those of pol­
icy makers [32]. Inclusion of different perspectives is 
important, to enhance the legitimacy of the priority set­
ting process, as has been acknowledged in the Account­
ability for Reasonableness framework [33]. The present 
study is a first step to integrate different views, by docu­
menting differences and similarities. The study did not 
aim to reach consensus by the different stakeholders, and 
it is not sure which methodology could be used to accom­
modate this. A challenge here is to avoid dominance by 
one group stakeholder (e.g. policy makers) over another 
(e.g. community members).
The DCE in this study only includes the criteria that 
were found to overlap from the focus group discussions. 
The rationale for doing so was to accommodate compara­
bility of study findings (so to include identical criteria in 
DCE for the various stakeholders) on the one hand, while 
maintaining the number of criteria to a manageable num­
ber (thus not including all possible criteria that were put 
forward by any discussion group) on the other hand. 
However, this choice may have led to the omission of 
important criteria for some groups of stakeholders, and 
may have reduced the validity of study findings. Next 
studies should seek to strike a balance between compara­
bility and validity.
Our study findings are based on small sample sizes 
(ranging from 28 for policy makers, to 74 for PLWHA), 
and should therefore be interpreted with caution. This 
also indicates the explorative character of our study. A 
proper sample size calculation is difficult in the absence a 
prior information on the variances on the responses - we 
based our sample sizes on previous similar studies, e.g. in 
Ghana [23] and Nepal [24] that also included a limited 
number of respondents.
Intervention utility can be calculated by assuming a 
main effects additive utility model on the basis of a linear 
combination of the weights of each level of all criteria 
[28]. This utility can then be compared to costs, to deri­
vate a cost-utility estimate. Subsequently, interventions 
can then be rank ordered on the basis of these cost-utility 
estimates, and this rank ordering reflects the overall 
intervention attractiveness. A rank ordering of HIV/
Youngkong et al. BMC Health Services Research 2010, 10:197 Page 8 of 9
http://www.biomedcentral.com/1472-6963/10/197
AIDS interventions on the basis of cost-utility informa­
tion can be used to inform policy decision making, and is 
topic for further research. This is conceptually more con­
sistent approach than considering cost-effectiveness as a 
separate criterion, as applied in other similar studies 
[23,25]. However, cost-effectiveness as a separate crite­
rion also has much appeal to policy makers, and is not 
clear which approach is best in supporting decision in 
real-life.
The present study findings, and associated rank order­
ing of HIV/AIDS interventions, can be considered as gen­
eral principles to prioritization of HIV/AIDS 
interventions in Thailand. Since the DCE design only 
involves a set of criteria amendable to quantification, it 
ignores a range of non-quantifiable considerations - e.g. 
ethical, political, and social concerns [34,35]. As such, any 
rank ordering of intervention can be indicative only, and 
should never be interpreted in a mathematical manner. In 
this respect, a broad clustering or typology of interven­
tions that are probable 'good candidates for implementa­
tion', 'not good candidates for implementation', and 'in- 
between' is perhaps a good way to present results to pol­
icy makers. Such a broad typology is then a starting point 
for a more detailed priority setting process, in which pol­
icy makers can still deviate from the broad recommenda­
tions. A deliberative process is able to include the non­
quantitative criteria and can encourage participatory 
approaches with a variety of stakeholders and interests 
[36,37].
This exploratory study has shown the feasibility of elic­
iting explicit preferences on the criteria for prioritization 
of HIV/AIDS interventions in Thailand. Further studies 
should refine methodological aspects, and interpret the 
findings in terms of the prioritization of interventions.
Additional material
Additional file 1 The DCE questionnaire. The questionnaire presents the 
DCE questions and explanatory notes used in the survey (10 pages)
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